Incobotulinumtoxina Intramuscular and Insulin Degludec (U-100) Vials
Determining the interaction of Incobotulinumtoxina Intramuscular and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: incobotulinumtoxinA
Brand name: Xeomin
Synonyms: Incobotulinumtoxina (Intramuscular)
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incobotulinumtoxina Intramuscular-Insulin Degludec (U-200) Prefilled Pens
- Incobotulinumtoxina Intramuscular-Insulin degludec and liraglutide
- Incobotulinumtoxina Intramuscular-Insulin degludec and liraglutide Subcutaneous
- Incobotulinumtoxina Intramuscular-Insulin degludec Subcutaneous
- Incobotulinumtoxina Intramuscular-Insulin detemir
- Incobotulinumtoxina Intramuscular-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Increlex
- Insulin Degludec (U-100) Vials-Incruse Ellipta
- Insulin Degludec (U-100) Vials-Indacaterol
- Insulin Degludec (U-100) Vials-Indacaterol and Glycopyrrolate
- Insulin Degludec (U-100) Vials-Indacaterol and glycopyrrolate Inhalation
- Insulin Degludec (U-100) Vials-Indacaterol inhalation